Most Read
Most Commented
mk-logo
News
Kanger gets biotechnology board's greenlight on China Covid-19 vaccine
Published:  Nov 23, 2020 4:40 PM
Updated: 10:49 AM

COVID-19 | Kanger International Berhad announced that the National Institutes of Biotechnology Malaysia (NIBM) has issued a letter stating it has no objections for the company to communicate with Sinopharm to purchase Covid-19 vaccines for private sector use in Malaysia.

This followed Kanger’s announcement on Sept 29 that the group, which is chaired by former deputy minister Nur Jazlan Mohamed, entered into a three-year collaboration agreement with Sinopharm Group Hunan Changde Medical Co Ltd.

The deal is for the distribution of Covid-19 vaccines and medical equipment in Malaysia developed by China National Pharmaceutical Group Corporation (Sinopharm)...


Please join the Malaysiakini WhatsApp Channel to get the latest news and views that matter.

Unlocking Article
Unlocking Article
View Comments
ADS